| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T529 |
0-27 |
Sentence |
denotes |
Clinical Trial Intervention |
| T530 |
28-176 |
Sentence |
denotes |
NCT04331795 (COVIDOSE)NCT04320615 (COVACTA)NCT04332913 (TOSCA)NCT04317092 (TOCOVID-19)NCT04335071 (CORON-ACT)NCT04315480ChiCTR2000029765 tocilizumab |
| T531 |
177-198 |
Sentence |
denotes |
NCT04315298 sarilumab |
| T532 |
199-233 |
Sentence |
denotes |
NCT04310228 tocilizumabfavipiravir |
| T533 |
234-317 |
Sentence |
denotes |
NCT04306705 (TACOS) tocilizumabcontinuous renal replacement therapystandard of care |
| T534 |
318-381 |
Sentence |
denotes |
NCT04332094 (TOCOVID) tocilizumabazithromycinhydroxychloroquine |
| T535 |
382-449 |
Sentence |
denotes |
NCT04341870 (CORIMUNO-VIRO) sarilumabazithromycinhydroxychloroquine |
| T536 |
450-517 |
Sentence |
denotes |
NCT0433z638 (COV-AID) tocilizumabsiltuximabanakinrastandard of care |
